Metaraminol 5mg10ml solution for injection ampoules

Main information

  • Trade name:
  • Metaraminol 5mg10ml solution for injection ampoules
  • Dosage:
  • 500microgram/1ml
  • Pharmaceutical form:
  • Solution for injection
  • Class:
  • No Controlled Drug Status
  • Prescription type:
  • Valid as a prescribable product
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • Metaraminol 5mg10ml solution for injection ampoules
    United Kingdom
  • Language:
  • English

Therapeutic information

  • Product summary:
  • BNF: ; GTIN: 5060131263199

Other information

Status

  • Source:
  • eMC
  • Last update:
  • 19-02-2019

28-11-2018

Prenoxad 1 mg/mL solution for injection (naloxone hydrochloride)

Prenoxad 1 mg/mL solution for injection (naloxone hydrochloride)

Update - medicine shortage

Therapeutic Goods Administration - Australia

13-7-2018

Hospira Issues Voluntary Nationwide Recall of Daptomycin for Injection Lyophilized Powder for Solution, Due to Infusion Reactions

Hospira Issues Voluntary Nationwide Recall of Daptomycin for Injection Lyophilized Powder for Solution, Due to Infusion Reactions

Hospira, Inc., a Pfizer company, is voluntarily recalling 8 lots of Hospira’s Daptomycin for Injection 500 mg, Lyophilized Powder For Solution, Single Dose Vial (NDC 0409-0106-01) to the Hospital/Retail level. The product is being recalled due to adverse event reports indicative of infusion reactions.

FDA - U.S. Food and Drug Administration

There are no news related to this product.